cedars-sinai.org
USA Today: Crohn's Disease Is a Lifelong Condition, But Proper Treatment Makes All the Difference
This article reassures people with Crohn’s that newer medications can control inflammation and lower complication and surgery risk. It also highlights the kinds of complications to watch for and ongoing research into diet.
Adults with Crohn’s disease (especially newly diagnosed), caregivers, and clinicians managing IBD
What To Know
USA Today interviewed a Cedars‑Sinai IBD clinician about Crohn’s disease, emphasizing that it is a lifelong condition without a cure but that newer treatments help control inflammation and reduce surgery rates.
The piece highlights common complications (fistula, abscess, bowel obstruction from scar tissue/stricture) and notes that therapies work by damping an overactive immune response. The article also mentions ongoing research into diet’s role in treatment.
Improved medications for Crohn’s disease over the past decade can better manage symptoms and lower the risk of severe complications and need for surgery. The clinician quoted explains that many current therapies target the immune system to reduce inflammation.
The article explains common complications such as strictures leading to bowel obstruction, fistula formation, and abscess, which can become serious if untreated.
If you want more detail, the original USA Today piece is linked in the Cedars‑Sinai post; this summary reflects the interview content reported there without adding new study data or treatment recommendations.
This is a clinician interview summarized for a general audience, not a report of a new clinical trial. It describes current treatment approaches and common complications but does not provide specific study data or treatment guidance.
